期刊文献+

MMP-2和TIMP-2在甲状腺乳头状癌中的表达及意义

THE EXPRESSION AND SIGNIFICANCE OF MATRIX METALLOPROTEINASE-2 AND TISSU E INHIBITOR OF METALLOPROTEINASE-2 IN PAPILLARY THYROID CARCINOMA
原文传递
导出
摘要 目的 :探讨基质金属蛋白酶 -2 (MMP-2 )和组织基质金属蛋白抑制剂 -2 (TIMP-2 )在人甲状腺乳头状癌组织中的表达及其与浸润程度、淋巴结转移的关系。方法 :应用免疫组织化学 S-P法对 56例甲状腺乳头状癌组织及其癌旁正常甲状腺组织中 MMP-2和 TIMP-2表达情况进行检测。结果 :MMP-2和 TIMP-2在甲状腺乳头状癌组织中表达的阳性率分别为 76.8% (43 / 56)和 3 7.5%(2 1/ 56)。在癌旁正常甲状腺组织中表达的阳性率分别为 3 3 .9% (19/ 56)和 3 2 .1% (18/ 56) ,表明MMP-2在甲状腺乳头状癌中有较高表达率。同时 MMP-2和 TIMP-2的表达与浸润程度、淋巴结转移有显著相关性 (P<0 .0 5) ,与肿瘤大小无相关性。结论 :MMP-2和 TIMP-2的表达与甲状腺乳头状癌浸润程度、淋巴结转移密切相关 。 Objective:To study the expression of Matrix Metall oproteinase-2(MMP-2) and Tissue Inhibitor of Metalloproteinase-2(TIMP-2) in Papillary Thyroid Carcinomas(PTL) tissues and the relationship with degree of th e infiltration and lymph node metastasis.Methods:Using S-P immunohistochemical methods,we examined the e xpression of MMP-2 and TIMP-2 in 56 PTC tissues and adjacent follicular epithe lia.Results:The positive expression rates of MMP-2 and TIMP-2 in P TC were 76.8 %(43/56),and in the adjacent follicular epithelia to cancerous tiss ue were 33.9 %(19/56) and 32.1 %(18/56).The expression of MMP-2 in PTC was sign ificantly higher than those in the adjacent follicular epithelia.The expression of MMP-2 and TIMP-2 were not correlated with size of tumour.The expression of MMP-2 and TIMP-2 were correlated to the degree of the infiltration and lymph n ode metastasis in PTC.Conclusion:The expression of MMP-2 and TIMP-2 were closely cor related to the degree of infiltration and lymph node metastasis in PTC,which may serve as one of the parameters for determing biological behavior and prognosis of PTC.
出处 《肿瘤研究与临床》 CAS 2003年第5期297-299,共3页 Cancer Research and Clinic
关键词 甲状腺乳头状癌 基质金属蛋白酶-2 组织基质金属蛋白抑制剂-2 免疫组织化学 预后 Papillary thyroid carcinoma Matrix Metalloproteinase -2 Tissue inhibitor of metalloproteinase-2 Immunohistochemistry Prognosis
  • 相关文献

参考文献8

  • 1Kraiem Z, Korem S. Matrix metalloproteinase and thyroid [J].Thyroid, 2000,10(12) : 1016. 被引量:1
  • 2Kauayama H O. Yokota K. Kurokawa Y,et al. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of melalloproteinase-2 expressin in bladder cancer[J]. Cancer, 1998,82(7): 1359. 被引量:1
  • 3Liotta L A,Steeg P S,Stetler Stevenson W G. Cancer metastasis and angiogenesis :an imbalance of positive and negative regulation[J ]. Cell ,1991,64(2) :327. 被引量:1
  • 4Komorowski J, Pasieka Z, J ankiewicz-Wika J et al. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer[J ]. Thyroid, 2002 ; 12 (8) : 655. 被引量:1
  • 5Nakamura H, Ueno H, Yamashita K,et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas[J]: Cancer Res,1999,59(2) :467. 被引量:1
  • 6Parsons S L, Watson S A, Colllins H M, et al. Gelatinase(MMP-2 and MMP-9) expression in gastrointestinal malignancy[J]. Br J Cancer,1998,78(11):1496. 被引量:1
  • 7Maeta H.Ohgi S,Terada T. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproleinase 1 and 2 in papillary thyroid carcinomas[J]. Virchows Arch, 2001,438(2) : 121. 被引量:1
  • 8孙建新,张从昕,殷学平,吴祥甫.重组金属蛋白酶抑制因子-3抗肿瘤作用的实验研究[J].中华肿瘤杂志,1998,20(4):287-289. 被引量:16

二级参考文献2

  • 1Sun Y,Cancer Res,1994年,54卷,1139页 被引量:1
  • 2武利存,山东省医学科学院学报,1992年,1期,16页 被引量:1

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部